Evidence map›Paper›PMID 33193880›Full record

ArticleJournal of Cancer2020

Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma.

Xia Yu, Fugui Li, Weimin Cheng, Biaohua Wu, Huiyun Fang, Fuzhen Xia, Yijun Gong, Wenjing Yu, Pu Liao, Youde Cao and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Xia YuCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Fugui LiCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Weimin ChengCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Biaohua WuCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Huiyun FangCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Fuzhen XiaGuangdong Provincial Engineering Technology Research Center for Autoimmune Laboratory Diagnostic Products, Shenzhen, Guangdong, China.
Yijun GongGuangdong Provincial Engineering Technology Research Center for Autoimmune Laboratory Diagnostic Products, Shenzhen, Guangdong, China.
Wenjing YuDepartment of Clinical Laboratory, First Hospital of Jilin University, Changchun, Jilin, China.
Pu LiaoDepartment of Clinical Laboratory, Chongqing General Hospital, Chongqing, China.
Youde CaoDepartment of Clinical Laboratory, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan, China.
Fenghua YangDepartment of Clinical Laboratory, Fushun Central Hospital, Fushun, Liaoning, China.
Hong ZhuDepartment of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Jiang LiDepartment of Clinical Laboratory, Shenzhen Sixth People's Hospital (Nanshan Hospital), Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, Guangdong, China.
Yajun HuangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Fujian Medical University (Donghai Hospital District), Quanzhou, Fujian, China.
Liying GanDepartment of Clinical Laboratory, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi, China.
Lei ZhangDepartment of Clinical Laboratory, Capital Medical University Daxing Teaching Hospital, Beijing, China.
Yonggang LouDepartment of Clinical Laboratory, Dongyang People's Hospital, Dongyang, Zhejiang, China.
Mingfang JiCancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
Zhongshan People's Hospital · CNCapital Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CNFirst People's Hospital of Chongqing · CNHunan Normal University · CNJilin University · CNLiaoning Shihua University · CNSecond Affiliated Hospital of Fujian Medical University · CNShenzhen Sixth People's Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CLIAEBNA1-IgAELISAnasopharyngeal carcinomaVCA-IgA

Identifiers

PMID33193880
PMCPMC7646185
OpenAlexW3097309576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.